Cellular and molecular mechanisms of TNF protection in septic peritonitis

Journal of Inflammation

Volumn 47, Issue 1-2, 1995, Pages 85-89

  Echtenacher, Bernd ^a   Hühner, Lothar ^a   Männel, Daniela N ^a  

^a Dept of Pathology Tumorimmunology ^*  (Germany)

Author keywords

fibrin; inflammation; mast cells; sepsis

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL PERITONITIS; CONTROLLED STUDY; FIBRIN FORMATION; GRANULOCYTE FUNCTION; IMMUNE RESPONSE; IMMUNOREGULATION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; FIBRIN; HUMANS; MAST CELLS; MICE; PERITONITIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029553849     PISSN: 10787852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Echtenacher B, Falk W, Männel DN, Krammer PH: Requirement of endogenous tumor necrosis factor/ cachectin for recovery from experimental peritonitis. J Immunol 145:3762-3766, 1990.
2. Urbaschek B, Ditter B, Becker KP, Urbaschek R: Protective effects and role of endotoxin in experimental septicemia. Circ Shock 14:209-222, 1984.
3. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
4. Rothstein JL, Schreiber H: Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sei U S A 85:607-611, 1988.
5. Echtenacher B, Falk W, Männel DN, Krammer PH: Survival from cecal ligation and puncture and the formation of fibrous adhesions in the peritoneal cavity depend on endogenous tumor necrosis factor. In Faist E, Meakins JL, Schildberg FW (eds): "Host Defense Dysfunction in Trauma, Shock and Sepsis." Berlin: Springer, 1993, pp 755-758.
6. McClean KL, Sheehan GJ, Harding GK: Intraabdominal infection: A review. Clin Infect Dis 19:100-116, 1994.
7. Clauss M, Ryan J, Stern D: Modulation of endothelial cell hemostatic properties by TNF: Insights into the role of endothelium in the host response to inflammatory stimuli. In Beutler B (ed): "Tumor Necrosis Factors." New York: Raven Press, 1992, pp 49-63.
8. Gamble JR, Smith WB, Vadas MA: TNF modulation of endothelial and neutrophil adhesion. In Beutler B (ed): "Tumor Necrosis Factors." New York: Raven Press, 1992, pp 65-86.
9. Lopez AF, Strath M, Sanderson CJ: Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br J Haematol 57:489-494, 1984.
10. Yano H, Wershil BK, Arizono N, Galli SJ: Substance Pinduced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent J Clin Invest 84:1276-1286, 1989.
11. Ramos BF, Zhang Y, JakschikBA: Mast cells contribute to fibrin deposition in reverse passive Arthus reaction in mouse skin. Eur J Immunol 22:2381-2385, 1992.
12. Galli SJ, Kitamura Y: Genetically mast-cell-deficient W/ Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol 127:191-198, 1987.
13. Malaviya R, Ikeda T, ROSS E, Abraham SN: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-oc. Nature 381:77-80, 1996.
14. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-alpha/ cachectin. Nature 346:274-276, 1990.
15. αlphal/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism forthe sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 174:103-107, 1991.
16. Sher A, Hein A, Moser G, Caulfield JP: Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab Invest 41:490-499, 1979.
17. Vranian G, Jr., Conrad DH, Ruddy S: Specificity of C3 receptors that mediate phagocytosis by rat peritoneal mast cells. J Immunol 126:2302-2306, 1981.
18. Otani I, Conrad DH, Carlo JR, Segal DM, Ruddy S: Phagocytosis by rat peritoneal mast cells: independence of IgG Fc-mediated and C3-mediated signals. J Immunol 129:2109-2112, 1982.
19. Malaviya R, ROSS E, Jakschik BA, Abraham SN: Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J Clin Invest 93:1645-1653, 1994.
20. Echtenacher B, Männel DN, Hiiltner L: Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75-77, 1996.
21. Matsuda H, Kawakita K, Kiso Y, Nakano T, Kitamura Y: Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunol 142:927-931, 1989.
22. Ansel JC, Brown JR, Payan DG, Brown MA: Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 150:4478-4485, 1993.
23. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J: Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:129-135, 1995.
24. Waage A, Halstensen A, Espevik T: Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357, 1987.